Table 3 Comparison between treated and control groups (no of cores per patient).

Initial biopsies	No of cores	Repeat biopsies
		Monofocal HGPIN	Plurifocal HGPIN
Monofocal HGPIN
Treated group	1	1	0
Controls	1	1	0
Plurifocal HGPIN
Treated group	3 (2–5)*	1	0
Controls	4 (2–6)*	0	4 (2–7)*

HGPIN, high‐grade prostatic intraepithelial neoplasia; PCa, prostate adenocarcinoma;

*Mean and range